ENTRY       K03989                      KO
NAME        C4
DEFINITION  complement component 4
PATHWAY     ko04610  Complement and coagulation cascades
            ko05133  Pertussis
            ko05150  Staphylococcus aureus infection
            ko05322  Systemic lupus erythematosus
DISEASE     H00080  Systemic lupus erythematosus
            H00102  Classic complement pathway component defects
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Organismal Systems
              Immune system
               04610 Complement and coagulation cascades
                K03989  C4; complement component 4
             Human Diseases
              Immune diseases
               05322 Systemic lupus erythematosus
                K03989  C4; complement component 4
              Infectious diseases
               05133 Pertussis
                K03989  C4; complement component 4
               05150 Staphylococcus aureus infection
                K03989  C4; complement component 4
            Exosome [BR:ko04147]
             Exosomal proteins
              Exosomal proteins of hepatic cells
               K03989  C4; complement component 4
              Exosomal proteins of other cancer cells
               K03989  C4; complement component 4
GENES       HSA: 720(C4A) 721(C4B)
            PTR: 100616513 462577(C4A)
            PPS: 100988452(C4A)
            GGO: 101146168 101148680
            PON: 100171517(C4B)
            MCC: 721200(C4B)
            MCF: 102123546(C4A) 102132156(C4B)
            MMU: 12268(C4b)
            RNO: 24233(C4a)
            CGE: 100767983(C4a)
            HGL: 101719002(C4a)
            TUP: 102483263(C4A)
            CFA: 481722(C4A)
            AML: 100475765(C4B)
            FCA: 101094346(C4A)
            PTG: 102967020(C4A)
            BTA: 100852118 280678(C4A) 617696
            PHD: 102318067 102318421 102319114
            CHX: 102177484 102177890 102189753
            SSC: 445467(C4)
            CFR: 102521056(C4A)
            BACU: 103015179(C4A)
            LVE: 103087928(C4A)
            ECB: 100059239(C4A)
            MYB: 102254455(C4A)
            MYD: 102774999(C4A)
            PALE: 102898626(C4A)
            MDO: 100025543(C4A)
            SHR: 100923960
            GGA: 418892 426611(C4)
            MGP: 100538976
            TGU: 100231134
            FAB: 101810518(C4A)
            PHI: 102114525(C4A)
            APLA: 101795032 101798073(C4A)
            FPG: 101924008(C4B)
            FCH: 102048743(C4B)
            CLV: 102094160(C4A)
            ASN: 102383747(C4A)
            AMJ: 102568973
            PSS: 102454722(C4A)
            CMY: 102944866(C4A)
            ACS: 100554736(c4b)
            PBI: 103061759 103063425(C4A)
            XLA: 394275(c4a)
            XTR: 100135012(c4a)
            DRE: 566261(c4) 794635
            TRU: 101065354
            MZE: 101471515 101471809
            OLA: 100049261(c4b)
            XMA: 102220196
            LCM: 102346391
            CMK: 103189476 103189738 103191458
            BFO: BRAFLDRAFT_129974
REFERENCE   PMID:2395880
  AUTHORS   Carroll MC, Fathallah DM, Bergamaschini L, Alicot EM, Isenman DE
  TITLE     Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.
  JOURNAL   Proc Natl Acad Sci U S A 87:6868-72 (1990)
///
